HEAVy HAT-HEAlthy Volunteers Heart to Arm Time. Haemorrhage Simulation Protocol in Healthy Volunteers
NCT02177188 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2014-06-27
Summary
In prehospital settings, hypovolemic shock diagnosis is based on Advanced Trauma Life Support (ATLS) shock classification. The most often used clinical signs are heart rate (HR), arterial blood pressure (BP), respiratory rate, neurologic status, diuresis, skin colour and temperature. However, some of these signs, such as hypotension and tachycardia, lack specificity and sensitivity and do not occur early enough. Even with an early preload reduction, blood pressure can remain constant due to compensatory mechanisms, such as vasoconstriction and positive chronotropism. Tachycardia occurs earlier, but has poor specificity and sensitivity. A retrospective analysis of 25,287 trauma patients showed that among 489 patients presenting with systolic BP \< 90 mmHg, only 65% had tachycardia (HR \> 90 bpm), while 39% of patients with systolic BP \> 120 mmHg were tachycardic, probably resulting from other stimuli influencing heart rate, such as pain, fear, circulating hormones and endogenous enkephalins. Therefore, it could be very useful to have an index that identifies initial volume variation, when physiological regulatory mechanisms are still effectively maintaining normal BP.
Pulse transit time (PTT) is the sum of pre-ejection period (PEP; the time interval between the onset of ventricular depolarization and ventricular ejection) and vascular transit time (VTT; the time it takes for the pulse wave to travel from the aortic valve to peripheral arteries). PEP and VTT variations depend on preload variation, and PTT increases with PEP, showing a linear correlation (R2 = 0.96). Chan et al. subjected 11 healthy volunteers to the head-up tilt test, and demonstrated that PEP increased and VTT decreased for increasing tilt angles from 0° to 80°, corresponding to light-moderate bleeding. They also observed early sympathetic activation, expressed by decreases of both RR interval (RR) and VTT, dampening the PTT increase, since PTT is influenced by both continuous PEP increase and progressive VTT decrease occurring during hypovolaemia.
Here the investigators describe a new index, called indexed Heart to Arm Time (iHAT). iHAT is the mPTT/RR ratio, where mPTT is a modified PTT, measured from the onset of ventricular depolarization (the 'R' wave of the ECG trace) to the systolic peak of the photoplethysmographic pulse oxymetry (PPG) waveform. mPTT is indexed to RR interval on ECG to counteract sympathetic activation that would dampen PEP increase and enhance VTT reduction, by means of positive inotropism and peripheral vasoconstriction, respectively. iHAT therefore increases during haemorrhage because of preload reduction and the consequent PEP increase and RR interval decrease. iHAT is expressed as the time percentage of the interbeat interval (RR) it takes to the PPG waveform to travel to peripheral arteries. In this study iHAT has been calculated as the average of beat-to-beat mPTT/RR ratios over 30 heart beats (corresponding to at least 2 breathing cycles) in order to minimize the effect of spontaneous breathing on preload, and thus on PEP and PTT.
In the present study, the investigators aimed to evaluate iHAT in a simulating model of hypovolaemia by using a Lower Body Negative Pressure (LBNP) chamber. LBNP chamber simulates haemorrhage by applying negative pressure to the lower limbs, thus giving an accurate model of hypovolemia. The LBNP chamber has been used for many years for research purposes, and in 2001 Convertino suggested it is a useful device to test severe haemorrhage-related hemodynamic responses. In fact, the induced volemic sequestration is an efficient technique to study physiological behaviours in humans.
The primary endpoint was to evaluate the use of the iHAT as a predictor of hypovolaemia. The secondary endpoint was to compare the specificity and sensitivity of the iHAT index compared to commonly used indexes (BP, HR). Furthermore, the investigators aimed to assess feasibility of Transthoracic echocardiography (TTE) evaluation of Cardiac Output (CO) in a haemorrhagic model and to evaluate CO changes with respect to measured hemodynamic variables.
TTE evaluation of CO is non invasive and comparable to thermodilution, and of possible use in an emergency setting.
Conditions
- Shock
Interventions
- DEVICE
-
LBNP Lower Bodi Negative Pressure Chamber
Sponsors & Collaborators
-
University of Milano Bicocca
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-08-31
- Completion
- 2012-09-30
Countries
- Italy
Study Locations
More Related Trials
-
"Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools"
NCT04934943 ·Status: NOT_YET_RECRUITING
-
Continuous Central Venous Lactate Monitoring by Intravascular Microdialysis : a Comparison to Sequential Arterial Lactate Measurement During Shock.
NCT03464747 ·Status: COMPLETED
-
Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
NCT00113685 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Goal-directed thErapy oN cIrcUlatory Shock
NCT05336357 ·Status: RECRUITING ·Phase: NA
-
PCO2 Gab Marker of Tissue Adequacy of Cardiac Output in Shock State
NCT05679778 ·Status: UNKNOWN
-
Evaluation of the Variation of the Sub-pulmonary Velocity-time Integral to Predict Fluid Responsiveness
NCT07202637 ·Status: RECRUITING
-
Fluid Responsiveness Prediction at the Bedside
NCT00721604 ·Status: COMPLETED
-
Pilot Validation of a Hemodilution Technique to Estimate Blood Volume in Vivo
NCT03031600 ·Status: UNKNOWN ·Phase: NA
-
Hemodynamic Monitoring and Fluid Responsiveness in Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) - "HemodynamECMOnitoring-VV Study"
NCT06593717 ·Status: RECRUITING ·Phase: NA
-
RApid Fluid Volume EXpansion in Patients in Shock After the Initial Phase of Resuscitation.
NCT02645851 ·Status: TERMINATED ·Phase: NA
-
Timing and Dose of Fluid Deresuscitation in Critically Ill Patients
NCT07275658 ·Status: RECRUITING
-
Impact of Fluid Management Within a Goal-directed Hemodynamic Protocol on Acid-base Balance in Elective Trauma Surgery
NCT01117519 ·Status: COMPLETED ·Phase: PHASE4
-
Time Course Evolution of Cardiac Output
NCT03694717 ·Status: COMPLETED
-
Fluid Challenges in Intensive Care
NCT01787071 ·Status: COMPLETED
-
Transcutaneous pO2, Transcutaneous pCO2 and Central Venous SO2 Variations to Define Fluid Responsiveness
NCT01941472 ·Status: COMPLETED ·Phase: NA
-
Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.
NCT04533997 ·Status: COMPLETED ·Phase: PHASE3
-
Aggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy
NCT02067195 ·Status: UNKNOWN ·Phase: NA
-
Tailored Hydration Based on Bioimpedance Analysis for Prevention of Contrast Induced Acute Kidney Injury
NCT04215042 ·Status: UNKNOWN ·Phase: NA
-
Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients
NCT01309724 ·Status: COMPLETED ·Phase: NA
-
Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome Patients
NCT04219150 ·Status: COMPLETED ·Phase: NA
-
Relieve the Patient's Thirst, Refresh the Mouth First (ICU-MIC)
NCT03610074 ·Status: COMPLETED ·Phase: NA
-
Thoracic Fluid Content During Hypervolemic Hemodilution
NCT04689516 ·Status: COMPLETED ·Phase: NA
-
End-expiratory Occlusion Test and Lung Recruitment Maneuver to Assess Fluid responsiVeness In Surgical Patients
NCT03820440 ·Status: UNKNOWN ·Phase: NA
-
Diagnosis Accuracy of Abdominal Compression and Hemoconcentration to Detect Diuretic Induced Fluid Removal Intolerance.
NCT03145935 ·Status: UNKNOWN
-
ACTIVE Study - Use of ACTIVE Fluid Exchange to Treat Intraventricular Hemorrhage
NCT05204849 ·Status: UNKNOWN ·Phase: NA